Cargando…
Mebendazole augments sensitivity to sorafenib by targeting MAPK and BCL-2 signalling in n-nitrosodiethylamine-induced murine hepatocellular carcinoma
Sorafenib (SO) is a multi-kinase inhibitor that targets upstream signals in the MAPK pathway. Drug resistance and transient survival benefits are the main obstacles associated with SO treatment in Hepatocellular carcinoma (HCC) patients. Mebendazole (MBZ), an anthelmintic agent, has demonstrated act...
Autores principales: | Younis, Nancy S., Ghanim, Amal M. H., Saber, Sameh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6911098/ https://www.ncbi.nlm.nih.gov/pubmed/31836811 http://dx.doi.org/10.1038/s41598-019-55666-x |
Ejemplares similares
-
Author Correction: Mebendazole augments sensitivity to sorafenib by targeting MAPK and BCL-2 signalling in n-nitrosodiethylamine-induced murine hepatocellular carcinoma
por: Younis, Nancy S., et al.
Publicado: (2022) -
Effect of Route of Administration on the Carcinogenic Action of Diethylnitrosamine (N-Nitrosodiethylamine)
por: Herrold, Katherine McD.
Publicado: (1964) -
Augmented Efficacy of Uttroside B over Sorafenib in a Murine Model of Human Hepatocellular Carcinoma
por: Swetha, Mundanattu, et al.
Publicado: (2022) -
Immunohistochemical, histopathological study and chemoprotective effect of Solanum nigrum in N-nitrosodiethylamine-induced hepatocellular carcinoma in Wistar rats
por: Akshatha, G. M., et al.
Publicado: (2018) -
Protective Effects of Garlic Oil on Hepatocarcinoma Induced by N-Nitrosodiethylamine in Rats
por: Zhang, Cui-Li, et al.
Publicado: (2012)